-

Nation’s PFAS Testing Leader, Eurofins Environment Testing USA, One of the First Commercial Laboratories to receive Accreditation for Draft Method 1633

LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF):

Eurofins Environment Testing laboratories in Sacramento, CA and Lancaster, PA announce that they have received accreditation for Draft EPA Method 1633 for the US Department of Defense under QSM 5.4 Table B-24 for all 40 PFAS compounds for water, solids and tissue matrices. These laboratories are some of the first commercial laboratories to receive this accreditation, further exemplifying the Eurofins network of laboratories as a leader in PFAS testing.

With 15 years of experience, Eurofins Environment Testing USA laboratories utilize gold-standard methods to support PFAS analysis and analyze an extensive list of matrices for PFAS contamination. This list includes, but is not limited to: potable and non-potable water; solids and biosolids; powders and micro-powders; AFFF; concrete; dispersants; leachate; biota, tissue and vegetation; soils, sediments, and sludge; viscous liquids; commercial products such as carpeting, packaging and other items; foods and dairy; and animal and human serum and whole blood. Eurofins Environment Testing USA supports emerging technologies such as Total Oxidizable Precursors (TOP) Assay, TOF/AOF/EOF, and Non-Target Analysis.

About Eurofins Environment Testing – USA

Operating 42 Environmental Testing Laboratories, multiple service centres and employing 3,000 staff, the Eurofins Environment Testing network in the US contributes to a clean and safe environment by providing market-leading laboratory testing, monitoring and consulting services to a wide range of industrial companies, environmental consultants, contractors, retailers and government authorities. With a keen focus on client service, regulatory compliance and defensible data, the Eurofins environmental laboratories network performs analysis of drinking water, groundwater, seawater, soil, air, and tissue using state-of-the-art analytical methods to assess quality and impact on health and the environment.

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With 58,000 staff across a network of 900 laboratories in 54 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

For further information:
Brooke Maharg
ir@eurofins.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

For further information:
Brooke Maharg
ir@eurofins.com

More News From Eurofins

Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples

LYON, France--(BUSINESS WIRE)--Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples. This innovation underlines Eurofins Biomnis’ diagnostic innovation, and its commitment to contributing its expert...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 02nd March to 06th March 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 30 000 67.7739 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 02/03/2026 FR0014000MR3 10 000 67.7248 CEUX EUROFINS SCIENTIFIC 529900JEHFM...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE – E1013 2. Identi...
Back to Newsroom